1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Implementation Science to Optimize HIV Prevention and Treatment is sponsored by National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA). NIDA seeks applications to inform, develop or test implementation science approaches to scale-up and sustain evidence-based HIV interventions among people who use drugs, incorporating care and prevention continua.
A range of settings can be considered (e.g., community, clinic, drug treatment, harm reduction, criminal-legal), and all levels of intervention (community, client/patient, provider, system). The full range of licit and illicit drugs that may affect HIV risk, prevention, and/or care are relevant.
This program aims to bridge the research-to-practice gap by promoting and supporting implementation science that uncovers how best to integrate evidence-based interventions for HIV prevention and treatment and associated conditions into real-world settings.
Studies should focus on innovative strategies to deliver biomedical prevention and treatment options toward ending the HIV epidemic, including strategies to optimize delivery, uptake, and adoption of novel long-acting therapeutic options, behavioral interventions to achieve viral suppression, strategies to address comorbidities in people with HIV, and practices that integrate and sustain evidence-based HIV prevention and care in various settings.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Applications must be relevant to the objectives of at least one of the participating NIH Institutes and Centers listed in the topic. Universities are typically eligible for NIH grants. Confirm the full requirements in the official notice before applying.
Implementation Science to Optimize HIV Prevention and Treatment is funded by National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Mechanisms, Models, Measurement, and Management in Pain Research is sponsored by National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA). This funding opportunity supports research on non-pharmacological and novel therapies for pain treatment, specifically mentioning virtual reality (VR). The NIH has a significant interest in VR's potential to treat pain and has funded numerous VR pain research projects.
Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) is sponsored by National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA). This program supports research on the mechanisms and targets at the intersection of HIV and substance use, which may include viral aspects of HIV infection in the context of substance abuse.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article